Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism-Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00823303
What this trial is testing

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Washington University School of Medicine 110
Large-scale testing (Phase 3)Study completedNCT01191762
What this trial is testing

Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease

Who this might be right for
HyperparathyroidismChronic Kidney Disease
Kenneth R. Phelps, M.D. 30
Not applicableStudy completedNCT00411294
What this trial is testing

Ergocalciferol in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Saint Louis VA Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Not applicableStudy completedNCT00427037
What this trial is testing

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Who this might be right for
Chronic Kidney DiseaseVitamin D Deficiency
Atlanta VA Medical Center 34
Large-scale testing (Phase 3)Study completedNCT01651000
What this trial is testing

Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondaryVitamin D Deficiency
OPKO IP Holdings II, Inc. 213
Testing effectiveness (Phase 2)Ended earlyNCT01439867
What this trial is testing

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, Secondary
Amgen 18
Testing effectiveness (Phase 2)Study completedNCT03960437
What this trial is testing

The Effect of Etelcalcetide on CKD-MBD

Who this might be right for
Chronic Kidney Disease Mineral and Bone DisorderRenal OsteodystrophyVascular Calcification+1 more
Thomas Nickolas, MD MS 22
Not applicableLooking for participantsNCT07007338
What this trial is testing

Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet

Who this might be right for
Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
Hospices Civils de Lyon 20
Post-approval studies (Phase 4)Study completedNCT03123406
What this trial is testing

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Kyowa Kirin China Pharmaceutical Co., Ltd. 750
Not applicableUnknownNCT04523974
What this trial is testing

Preemptive and Precise Intervention for CKD-SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT03960554
What this trial is testing

The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients

Who this might be right for
OsteoporosisRenal OsteodystrophyKidney Transplant; Complications
Thomas Nickolas, MD MS 8
Testing effectiveness (Phase 2)Study completedNCT00701805
What this trial is testing

Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)

Who this might be right for
Secondary HyperparathyroidismHemodialysis
Abbott 107
Post-approval studies (Phase 4)Study completedNCT03451019
What this trial is testing

Different Effects of Non-calcium Phosphate Binders on Serum Calcium

Who this might be right for
Chronic Kidney Disease
Medical University of Lodz 34
Post-approval studies (Phase 4)Ended earlyNCT00175149
What this trial is testing

Active Vitamin D Effect on Left Ventricular Hypertrophy

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismLeft Ventricular Hypertrophy
Per Ivarsen 24
Not applicableStudy completedNCT01640184
What this trial is testing

Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

Who this might be right for
HyperparathyroidismDisorders of Parathyroid Gland
Dongliang Zhang, MD 79
Testing effectiveness (Phase 2)Study completedNCT00560300
What this trial is testing

Regulation of Bone Formation in Renal Osteodystrophy

Who this might be right for
Secondary HyperparathyroidismRenal Osteodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 61
Not applicableStudy completedNCT04013139
What this trial is testing

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)

Who this might be right for
Ckd-Mbd
Shahid Beheshti University of Medical Sciences 200
Not applicableUnknownNCT04564924
What this trial is testing

To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Tongji Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02133404
What this trial is testing

Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Astellas Pharma Inc 62
Next Page